The Natural Products as Hydroxymethylglutaryl-Coa Reductase Inhibitors


Gulcan H. O. , Yigitkan S., ERDOĞAN ORHAN İ.

LETTERS IN DRUG DESIGN & DISCOVERY, vol.16, no.10, pp.1130-1137, 2019 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Review
  • Volume: 16 Issue: 10
  • Publication Date: 2019
  • Doi Number: 10.2174/1570180816666181112144353
  • Journal Name: LETTERS IN DRUG DESIGN & DISCOVERY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1130-1137
  • Keywords: HMG-CoA reductase, enzyme inhibition, hypercholesterolemia, natural products, statins, cholesterol, COENZYME-A REDUCTASE, CHOLESTEROL-BIOSYNTHESIS, CELL-PROLIFERATION, ALPHA-ASARONE, IN-VITRO, COMBINATION THERAPY, HMGCOA REDUCTASE, RAT HEPATOCYTES, STATIN, ACID
  • Gazi University Affiliated: Yes

Abstract

High cholesterol and triglyceride levels are mainly related to further generation of life-threating metabolism disorders including cardiovascular system diseases. Therefore, hypercholesterolemia (i.e., also referred to as hyperlipoproteinemia) is a serious disease state, which must be controlled. Currently, the treatment of hypercholesterolemia is mainly achieved through the employment of statins in the clinic, although there are alternative drugs (e.g., ezetimibe, cholestyramine). In fact, the original statins are natural products directly obtained from fungi-like molds and mushrooms and they are potent inhibitors of hydroxymethylglutaryl-CoA reductase, the key enzyme in the biosynthesis of cholesterol. This review focuses on the first identification of natural statins, their synthetic and semi-synthetic analogues, and the validation of hydroxymethylglutaryl-CoA reductase as a target in the treatment of hypercholesterolemia. Furthermore, other natural products that have been shown to possess the potential to inhibit hydroxymethylglutaryl-CoA reductase are also reviewed with respect to their chemical structures.